| Inducible nitric oxide synthase: Regulation, structure, and inhibition MA Cinelli, HT Do, GP Miley, RB Silverman Medicinal research reviews 40 (1), 158-189, 2020 | 732 | 2020 |
| Optimization of blood–brain barrier permeability with potent and selective human neuronal nitric oxide synthase inhibitors having a 2-aminopyridine scaffold HT Do, H Li, G Chreifi, TL Poulos, RB Silverman Journal of medicinal chemistry 62 (5), 2690-2707, 2019 | 44 | 2019 |
| Pharmacophore-based design of novel 3-hydroxypyrimidine-2, 4-dione subtypes as inhibitors of HIV reverse transcriptase-associated RNase H: tolerance of a nonflexible linker J Tang, HT Do, AD Huber, MC Casey, KA Kirby, DJ Wilson, J Kankanala, ... European journal of medicinal chemistry 166, 390-399, 2019 | 27 | 2019 |
| Chemical profiling of HIV-1 capsid-targeting antiviral PF74 L Wang, MC Casey, SKV Vernekar, HT Do, RL Sahani, KA Kirby, H Du, ... European journal of medicinal chemistry 200, 112427, 2020 | 24 | 2020 |
| Improvement of cell permeability of human neuronal nitric oxide synthase inhibitors using potent and selective 2-aminopyridine-based scaffolds with a fluorobenzene linker HT Do, HY Wang, H Li, G Chreifi, TL Poulos, RB Silverman Journal of medicinal chemistry 60 (22), 9360-9375, 2017 | 22 | 2017 |
| Enantioselective Synthesis of (−)-Dysiherbaine H Do, CW Kang, JH Cho, SR Gilbertson Organic letters 17 (16), 3972-3974, 2015 | 20 | 2015 |
| Synthesis and activity of benzimidazole-1, 3-dioxide inhibitors of separase HT Do, N Zhang, D Pati, SR Gilbertson Bioorganic & Medicinal Chemistry Letters 26 (18), 4446-4450, 2016 | 11 | 2016 |
| Potent, Selective, and Membrane Permeable 2-Amino-4-Substituted Pyridine-Based Neuronal Nitric Oxide Synthase Inhibitors D Vasu, HT Do, H Li, CD Hardy, A Awasthi, TL Poulos, RB Silverman Journal of medicinal chemistry 66 (14), 9934-9953, 2023 | 6 | 2023 |
| Pregabalin Treatment does not Affect Amyloid Pathology in 5XFAD Mice KR Sadleir, J Popovoic, W Zhu, CT Reidel, H Do, RB Silverman, R Vassar Current Alzheimer Research 18 (4), 283-297, 2021 | 4 | 2021 |
| Synthetic triterpenoids with nitrogen-based substituents at C-17 and methods of use thereof CF Bender, H Do, X Jiang, H Sun, M Visnick, I Janser, LJ Simons, ... WO Patent 2,021,127,480, 2021 | 2 | 2021 |
| C17 polar-substituted heteroaromatic synthetic triterpenoids and methods of use thereof X Jiang, CF Bender, H Do, SUN Haizhou, M Visnick US Patent App. 16/933,635, 2021 | 2 | 2021 |
| Correction to improvement of cell permeability of human neuronal nitric oxide synthase inhibitors using potent and selective 2-aminopyridine-based scaffolds with a … HT Do, HY Wang, H Li, G Chreifi, TL Poulos, RB Silverman Journal of medicinal chemistry 62 (2), 1074-1074, 2018 | 1 | 2018 |
| Synthesis of ursolic acid antioxidant inflammation modulators treating inflammation disorders and cancers X Jiang, H Do, H Sun, M Visnick, J Kral, Robert M. WO Patent 2,022,155,614, 2022 | | 2022 |
| Preparation of 2-aminopyridines as potent human neuronal nitric oxide synthase inhibitors for the treatment of neurological diseases RB Silverman, HT Do WO Patent 2,021,173,111, 2021 | | 2021 |
| Synthesis of dimeric compounds as STING agonists JR Duvall, KW Bentley, HT Do, BD Jones, NI Kauser, EW Kelleher, ... WO Patent 2,021,113,679, 2021 | | 2021 |
| Preparation of C17 polar-substituted heteroaromatic synthetic triterpenoids as antioxidant inflammation modulators X Jiang, CF Bender, H Do, H Sun, M Visnick US Patent 20,210,040,142, 2021 | | 2021 |
| Synthesis of Dysiherbaine and Separase Inhibitors in Drug Development for Neural Disorders and Breast Cancer HT Do | | 2015 |
| Synthesis of dysiherbaine and its analogs HT Do, SR Gilbertson ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY 245, 2013 | | 2013 |
| Supplementary Material Pregabalin Treatment does not Affect Amyloid Pathology in 5XFAD Mice KR Sadleir, J Popovoic, W Zhu, CT Reidel, H Do, RB Silverman, R Vassar | | |